Multiparticulate Formulation Strategies for Pediatric Drugs
Thursday, July 12th, 11 am (Eastern)
Getting children to take their medication is an age-old challenge. It’s not a spoonful of sugar, but effective formulation strategies, that offer the solution. Formulation acceptability has become a key criterion for developing new drugs that ensure patient compliance.
Solid oral products are increasingly preferred as a robust alternative to liquid preparations for pediatric applications. Oral solid approaches can reduce formulation complexity, conceal bitter taste effectively, and improve formulation safety and stability while maintaining dose flexibility and swallowability. Improving stability in particular, is critical in effectively reaching pediatric populations in developing countries where temperature extremes can be encountered and specializing handling is especially problematic.
In this webcast, experts will present and discuss:
Market and regulatory drivers for patient-centric formulations, with a focus on pediatric populations, but also a discussion of senior and other patient groups
Microparticulate technology options and technology selection rationale vs. specific formulation problem statements
Representative case studies that demonstrate the application of multiparticulate technology options
Speakers:
Sven Stagemann Director, Pharma BD, Lonza
Jaspreet Arora, Sr. Engineer Product Development Lonza Pharma & Biotech